21-Nov-2026 09:27:55

AUROPHARMAGeneral news

AUROPHARMA : USFDA CLOSES UNIT-VI INSPECTION WITH VAI CLASSIFICATION

• Unit-VI is an API manufacturing facility of Apitoria Pharma Private Limited, a wholly owned subsidiary of Aurobindo Pharma • Facility located at E-Bonangi Village, Parawada Mandal, Anakapalli District, Andhra Pradesh • USFDA inspected the site from August 24 to August 28, 2026 and concluded with three observations • Unit has now received the Establishment Inspection Report (EIR), classifying the facility as Voluntary Action Indicated (VAI) • USFDA has concluded that this inspection is now closed

Aurobindo Pharma Limited

Open attachment

← Back to feed